Immunocellular Therapeutics Stock Forecast

Buy or Hold candidate since May 26, 2026 Gain 145.21%

No changes to the price of ImmunoCellular Therapeutics Ltd stock on the last trading day (Monday, 13th Jul 2026). During the last trading day the stock fluctuated 0% from a day low at $0.270 to a day high of $0.270. The price has been going up and down for this period, and there has been a 22.68% gain for the last 2 weeks.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 111.69% during the next 3 months and, with a 90% probability hold a price between $0.397 and $0.706 at the end of this 3-month period.

IMUC Signals & Forecast

The ImmunoCellular Therapeutics Ltd stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.228 and $0.200. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, July 10, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for ImmunoCellular Therapeutics Ltd stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.252 and $0.212. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ImmunoCellular Therapeutics Ltd finds support just below today's level at $0.252. If this is broken, then the next support from accumulated volume will be at $0.212 and $0.208.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 1.21%

Our recommended stop-loss: $0.260 (-3.76%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (IMUC) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect ImmunoCellular Therapeutics Ltd to open at $0.270, and during the day (based on 14 day Average True Range), to move between $0.256 and $0.283, which gives a possible trading interval of +/-$0.0271 (+/-10.58%) up or down from last closing price. If ImmunoCellular Therapeutics Ltd takes out the full calculated possible swing range there will be an estimated 10.58% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.270 (0.04%) than the support at $0.252 (6.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ImmunoCellular Therapeutics Ltd stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ImmunoCellular Therapeutics Ltd stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 3.814 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $0.270 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk